CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

TD Cowen reiterated its Buy rating on Apollo Global Management (NYSE:APO) shares, maintaining a price target of $214.00.

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...

Cowen challenged students to rethink the intersection of society and artificial intelligence at a Yale Political Union debate ...

President Donald Trump appointed William Cowan as acting general counsel of the National Labor Relations Board Monday evening ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

Closely followed crypto analyst Benjamin Cowen says that a shift in monetary policy will most likely be what finally triggers an "altseason," or a period where altcoins vastly outperform Bitcoin (BTC) ...

TD Cowen analyst Jared Levine raised the firm’s price target on Paylocity (PCTY) to $242 from $228 and keeps a Buy rating on the shares. The ...

West, Barry Cowen, has warned that the potential for allies turning into adversaries in the wake of new US tariffs poses ...

TD Cowen analyst John Kernan maintained a Hold rating on Under Armour (UAA – Research Report) today and set a price target of $10.00. The ...

West, has voiced ‘serious concern’ following news that Nelipak Healthcare Packaging in Clara is seeking 40 voluntary ...